Exenatide Completed Phase 4 Trials for Myocardial Infarction / Hyperglycemia / Acute Coronary Syndrome (ACS) Treatment

Indications	Status	Purpose	Phase
DBCOND0027900 (Myocardial Infarction) DBCOND0020377 (Hyperglycemia) DBCOND0032938 (Acute Coronary Syndrome (ACS))	Completed	Treatment	4

clinicaltrials.gov Identifier	Title	Drugs
NCT00736229	Intravenous Exenatide in Coronary Intensive Care Unit (ICU) Patients	Exenatide (DB01276)